Keyphrases
Anemia
100%
Retrospective Analysis
100%
Pacritinib
100%
ACVR1
31%
IC50
18%
Platelet Count
12%
Hemoglobin Level
12%
Myelofibrosis
12%
Janus Kinase 2 (JAK2)
12%
Transfusion Independence
12%
Momelotinib
12%
In Vivo Analysis
6%
Transfusion
6%
Platelets
6%
Hemoglobin
6%
Transfusion Requirements
6%
Myelosuppression
6%
RBC Transfusion
6%
Janus Kinase 1 (JAK1)
6%
Anemic Patients
6%
Activin Receptor-like Kinase 2 (ALK2)
6%
Hepcidin
6%
Serial Dilution
6%
IRAK1 Inhibitor
6%
Biopharma
6%
Best Available Therapy
6%
Medicine and Dentistry
Anemia
100%
Pacritinib
100%
Platelet
18%
IC50
18%
Myelofibrosis
12%
Janus Kinase
12%
Momelotinib
12%
In Vitro
6%
Erythrocyte
6%
Bone Marrow Suppression
6%
Iron
6%
Hepcidin
6%
Serial Dilution
6%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
100%
Pacritinib
100%
IC50
18%
Janus Kinase
12%
Myelofibrosis
12%
Momelotinib
12%
Bone Marrow Suppression
6%
Iron
6%
Hepcidin
6%